drugset
drugset / Trial / NCT01054859

A Phase I Crossover Study of the Hemodynamic Interactions of Avanafil & Alcohol in Healthy Male Subjects.

NCT01054859 ↗

Phase 1 Completed 15 enrolled VIVUS LLC
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is primarily to evaluate whether taking avanafil with alcohol causes the blood pressure to fall.

Timeline

Start
2010-01
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Avanafil Small molecule 200 mg Oral

Indications

erectile dysfunction